Data / Form D filings / Cynapsus Therapeutics Inc.
Cynapsus Therapeutics Inc.: Form D filings
Cynapsus Therapeutics Inc., a pharmaceuticals company in Toronto, Ontario, Canada, filed 10 Form D notices with the SEC between 2011 and 2015. The latest, on April 14, 2015, reports $16.8 million sold of a $16.8 million offering to 14 investors.
Find out what Cynapsus Therapeutics Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 828 RICHMOND STREET WEST, Toronto, Ontario, Canada, M6J 1
- Phone
- (416) 703-2449
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Canada (Federal Level)
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1532079
The full lists. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 14, 2015 | New notice | $16,750,000 | $16,750,000 | $0 | 14 | Mar 31, 2015 | sec.gov |
| Apr 21, 2014 | New notice | $42,916,967 | $14,546,285 | $28,370,682 | 19 | Apr 15, 2014 | sec.gov |
| Mar 27, 2013 | Amendment | $13,017,911 | $4,124,454 | $8,893,457 | 5 | Mar 1, 2013 | sec.gov |
| Mar 20, 2013 | New notice | $2,449,104 | $0 | $2,449,104 | 10 | Yet to occur | sec.gov |
| Mar 15, 2013 | New notice | $11,225,543 | $3,923,190 | $7,302,353 | 5 | Mar 1, 2013 | sec.gov |
| Mar 28, 2012 | Amendment | $939,505 | $939,505 | $0 | 7 | Sep 29, 2011 | sec.gov |
| Jan 9, 2012 | Amendment | $761,610 | $761,610 | $0 | 6 | Sep 29, 2011 | sec.gov |
| Dec 28, 2011 | Amendment | $555,358 | $555,358 | $0 | 5 | Sep 29, 2011 | sec.gov |
| Nov 18, 2011 | Amendment | $389,144 | $389,144 | $0 | 3 | Sep 29, 2011 | sec.gov |
| Oct 13, 2011 | New notice | $222,368 | $222,368 | $0 | 2 | Sep 29, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Margaret Nan Hutchinson | Director | |
| Andrew Williams | Executive Officer | |
| Anthony Giovinazzo | Executive Officer, Director | |
| Thierry D. Bilbault | Executive Officer | |
| Tamar D. Howson | Director | |
| Ronald Hosking | Director | |
| Rochelle D. Stenzler | Director | |
| Ilan Nan Oren | Director | |
| Tomer Gold | Director | |
| Perry Nan Molinoff | Director |
Every Form D from the week of Apr 13, 2015 · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Cynapsus Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.